Immunological Risk Stratification by Assessing both the HLA and non-HLA Specific Antibodies: Time to Include Testing for Non-HLA Antibodies in the Routine Clinical Antibody Analysis Profile?.

No abstract available

http://ift.tt/2gQZAwJ